Dengue and dengue haemorrhagic fever
暂无分享,去创建一个
D. Gubler | G. Clark | V. Vorndam | P. Reiter | J. Rigau-Pérez | E. Sanders | Duane J Gubler | José G Rigau-Pérez | Paul Reiter | Gary G Clark | Eduard J Sanders | A Vance Vorndam | A. V. Vorndam
[1] N. M. Dung,et al. Evaluation of a Rapid Immunochromatographic Test for Diagnosis of Dengue Virus Infection , 1998, Journal of Clinical Microbiology.
[2] R. Dulbecco,et al. A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. , 1956, Virology.
[3] D. Gubler. Surveillance for dengue and dengue hemorrhagic fever. , 1989, Bulletin of the Pan American Health Organization.
[4] A. Nisalak,et al. A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.
[5] S. Halstead,et al. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels. , 1984, The American journal of tropical medicine and hygiene.
[6] D. Vuitton,et al. Nosocomial transmission of dengue from a needlestick injury , 1998, The Lancet.
[7] Rámirez-Ronda Ch,et al. Dengue in the Western Hemisphere. , 1994 .
[8] R. Wilkinson,et al. Rapid diagnosis and determination of duration of viraemia in dengue fever using a reverse transcriptase polymerase chain reaction. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[9] L. Rosen,et al. Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. , 1974, The American journal of tropical medicine and hygiene.
[10] D. Burke,et al. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. , 1989, The Journal of general virology.
[11] S. Hotta. Experimental studies on dengue. I. Isolation, identification and modification of the virus. , 1952, The Journal of infectious diseases.
[12] D. Gubler,et al. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. , 1995, Emerging infectious diseases.
[13] G. Kuno,et al. A case of natural concurrent human infection with two dengue viruses. , 1985, The American journal of tropical medicine and hygiene.
[14] A. Nisalak,et al. Early clinical and laboratory indicators of acute dengue illness. , 1997, The Journal of infectious diseases.
[15] J. Roux,et al. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and haemagglutination inhibition (HI) test for the detection of dengue antibodies. Prevalence of dengue IgG-ELISA antibodies in Tahiti. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[16] D. Gubler,et al. A program for prevention and control of epidemic dengue and dengue hemorrhagic fever in Puerto Rico and the U.S. Virgin Islands. , 1991, Bulletin of the Pan American Health Organization.
[17] D. Vaughn,et al. Impact of dengue virus infection on feeding behavior of Aedes aegypti. , 1997, The American journal of tropical medicine and hygiene.
[18] W. Bancroft,et al. Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. , 1984, The Journal of infectious diseases.
[19] P. Hobart,et al. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. , 1997, Vaccine.
[20] D. Gubler,et al. The use of mosquitoes to detect and propagate dengue viruses. , 1974, The American journal of tropical medicine and hygiene.
[21] G. Kuno,et al. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. , 1984, The American journal of tropical medicine and hygiene.
[22] M. Guzmán,et al. Advances in dengue diagnosis , 1996, Clinical and diagnostic laboratory immunology.
[23] D. Gubler,et al. Community-based integrated control of Aedes aegypti: a brief overview of current programs. , 1994, The American journal of tropical medicine and hygiene.
[24] P Winch,et al. Beliefs about the prevention of dengue and other febrile illnesses in Mérida, Mexico. , 1991, The Journal of tropical medicine and hygiene.
[25] D. Gubler,et al. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture. , 1989, The American journal of tropical medicine and hygiene.
[26] F. Pinheiro,et al. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. , 1997, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[27] J. Schlesinger,et al. Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses. , 1991, Virology.
[28] C. Peters,et al. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. , 1991, The American journal of tropical medicine and hygiene.
[29] A. Nisalak,et al. Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. , 1968, The American journal of tropical medicine and hygiene.
[30] R. DeFraites,et al. Dengue fever in US military personnel in Haiti. , 1997, JAMA.
[31] A. Sabin. Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.
[32] D. Gubler,et al. Epidemic dengue 3 in central Java, associated with low viremia in man. , 1981, The American journal of tropical medicine and hygiene.
[33] G. Kuno,et al. An ELISA procedure for the diagnosis of dengue infections. , 1991, Journal of virological methods.
[34] D. Gubler,et al. Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. , 1998, The American journal of tropical medicine and hygiene.
[35] A. Nisalak,et al. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.
[36] C. Kendall,et al. Effectiveness of community participation in vector-borne disease control , 1992 .
[37] W. Brandt. Development of dengue and Japanese encephalitis vaccines. , 1990 .
[38] P. Reiter,et al. A model of the transmission of dengue fever with an evaluation of the impact of ultra-low volume (ULV) insecticide applications on dengue epidemics. , 1992, The American journal of tropical medicine and hygiene.
[39] N. J. Ehrenkranz,et al. Pandemic dengue in Caribbean countries and the southern United States--past, present and potential problems. , 1971, The New England journal of medicine.
[40] A. Sabin,et al. PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE , 1945, Science.
[41] R. Lanciotti,et al. Phylogenetic relationships of dengue-2 viruses. , 1993, Virology.
[42] D. Hober,et al. Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients , 1993 .
[43] S. Lam,et al. Dengue encephalitis: a true entity? , 1996, The American journal of tropical medicine and hygiene.
[44] R. Lanciotti,et al. Molecular evolution and epidemiology of dengue-3 viruses. , 1994, The Journal of general virology.
[45] D. Gubler,et al. Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. , 1993, Infectious agents and disease.
[46] W. Bancroft,et al. Shock syndrome in primary dengue infections. , 1976, The American journal of tropical medicine and hygiene.
[47] Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. , 1958, The American journal of tropical medicine and hygiene.
[48] Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice , 1995, Journal of virology.
[49] P. Winch,et al. Vector control at the household level: an analysis of its impact on women. , 1994, Acta tropica.
[50] I M Longini,et al. Determinants and predictors of dengue infection in Mexico. , 1991, American journal of epidemiology.
[51] S. Lam,et al. Vertical transmission of dengue. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] S. Halstead. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.
[53] R. Rico-Hesse,et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. , 1997, Virology.
[54] M. K. Gentry,et al. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants , 1982, Infection and immunity.
[55] U. Thisyakorn,et al. Dengue infection with unusual manifestations. , 1994, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[56] T. Scott,et al. The effect of multiple host contacts on the infectivity of dengue-2 virus-infected Aedes aegypti. , 1995, Journal of Parasitology.
[57] S. Halstead,et al. Antibody-enhanced dengue virus infection in primate leukocytes , 1977, Nature.
[58] B. Niklasson,et al. Dengue fever among Swedish tourists. , 1993, Scandinavian journal of infectious diseases.
[59] M. Tidwell,et al. Cultural Factors in Aedes Aegypti and Dengue Control in Latin America: A Case Study from the Dominican Republic , 1989, International quarterly of community health education.
[60] G. Howe. A world geography of human diseases , 1979, Medical History.
[61] S. Halstead,et al. Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. , 1973, The Journal of infectious diseases.
[62] S. Nimmannitya. Dengue Fever/Dengue Haemorrhagic Fever : Case Management , 1995 .
[63] A. Nisalak,et al. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. , 1994, Archives of virology. Supplementum.
[64] Pinheiro Fp,et al. Dengue in the Americas. 1980-1987. , 1989 .
[65] Thet-Win. DETECTION OF DENGUE VIRUS BY IMMUNOFLUORESCENCE AFTER INTRACEREBRAL INOCULATION OF MOSQUITOES , 1982, The Lancet.
[66] M. Seguin,et al. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. , 1983, The American journal of tropical medicine and hygiene.
[67] H. Laferl. Pleural effusion and ascites on return from Pakistan , 1997, The Lancet.
[68] C. Kendall,et al. Effect of a community-based Aedes aegypti control programme on mosquito larval production sites in El Progreso, Honduras. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[69] Andrew J.Gordon. Mixed strategies in health education and community participation: an evaluation of dengue control in the Dominican Republic , 1988 .
[70] S. Yoksan,et al. Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. , 1987, Bulletin of the World Health Organization.
[71] B. Karp. Dengue fever: a risk to travelers. , 1997, Maryland medical journal (Baltimore, Md. : 1985).
[72] A. Nisalak,et al. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.
[73] S. Halstead. The XXth century dengue pandemic: need for surveillance and research. , 1992, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[74] Duane J. Gubler,et al. Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.
[75] C. Schofield. The politics of malaria vector control , 1993 .
[76] D. Focks,et al. A simulation model of the epidemiology of urban dengue fever: literature analysis, model development, preliminary validation, and samples of simulation results. , 1995, The American journal of tropical medicine and hygiene.
[77] M. Guzmán,et al. [Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas]. , 1996, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.
[78] S. Halstead,et al. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. , 1973, The Journal of infectious diseases.
[79] C. Wisseman,et al. Attenuated Living Type 1 Dengue Vaccines , 1963 .
[80] J. Roehrig,et al. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. , 1997, Virology.
[81] T. Scott,et al. A fitness advantage for Aedes aegypti and the viruses it transmits when females feed only on human blood. , 1997, The American journal of tropical medicine and hygiene.
[82] S. Halstead,et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.
[83] H. Gómez-Dantés,et al. Potential risk for dengue hemorrhagic fever: the isolation of serotype dengue-3 in Mexico. , 1996, Emerging infectious diseases.
[84] H. Casey. Standardized diagnostic complement fixation method and adaptation to micro test. , 1965, Public health reports.
[85] S. Nimmannitya,et al. Nutritional status of children with dengue hemorrhagic fever. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[86] M. Bray,et al. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[87] L. Rosen,et al. Experimental infection of chimpanzees with dengue viruses. , 1978, The American journal of tropical medicine and hygiene.
[88] M. Guzmán,et al. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. , 1998, Emerging infectious diseases.
[89] T. Ksiazek,et al. Viral hemorrhagic fevers , 1997 .
[90] S. Nimmannitya,et al. Dengue haemorrhagic fever with unusual manifestations. , 1987, The Southeast Asian journal of tropical medicine and public health.
[91] R. Tesh. A method for the isolation and identification of dengue viruses, using mosquito cell cultures. , 1979, The American journal of tropical medicine and hygiene.
[92] Karp Be. Dengue fever: a risk to travelers. , 1997 .
[93] S. Halstead. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. , 1970, The Yale journal of biology and medicine.
[94] W. Brandt,et al. Current Approaches to the Development of Dengue Vaccines and Related Aspects of the Molecular Biology of Flaviviruses , 1988 .
[95] R. Lanciotti,et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.
[96] L. Kit. Dengue infections with central nervous systemmanifestations. , 1996 .
[97] D. Gubler,et al. A simple technique for demonstrating transmission of dengue virus by mosquitoes without the use of vertebrate hosts. , 1976, The American journal of tropical medicine and hygiene.
[98] V. Deubel,et al. Demonstration of concurrent dengue 1 and dengue 3 infection in six patients by the polymerase chain reaction , 1991, Journal of medical virology.
[99] N. Bhamarapravati. Hemostatic defects in dengue hemorrhagic fever. , 1989, Reviews of infectious diseases.
[100] A. Nisalak,et al. Dengue virus identification by the plaque reduction neutralization test. , 1967, Journal of immunology.
[101] S. Halstead. Etiologies of the experimental dengues of Siler and Simmons. , 1974, The American journal of tropical medicine and hygiene.
[102] A. Nisalak,et al. Multicentre evaluation of dengue IgM dot enzyme immunoassay. , 1996, Clinical and diagnostic virology.
[103] R. Rico-Hesse,et al. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. , 1990, Virology.
[104] J. Roehrig,et al. Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes , 1992, Journal of virology.
[105] M. Guzmán,et al. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[106] L. Rosen. The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. , 1977, The American journal of tropical medicine and hygiene.
[107] S. Devi,et al. Detection of specific IgM in dengue infection. , 1987, The Southeast Asian journal of tropical medicine and public health.
[108] D. Gubler,et al. Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. , 1983, Bulletin of the World Health Organization.
[109] Benjamin Rush. An account of the bilious remitting fever: As it appeared in philadelphia, in the summer and autumn of the year 1780 , 1951 .
[110] D. Gubler,et al. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. , 1978, The American journal of tropical medicine and hygiene.
[111] C. Kendall,et al. The design of a community-based health education intervention for the control of Aedes aegypti. , 1994, The American journal of tropical medicine and hygiene.
[112] A. Nisalak,et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.
[113] G. Fox,et al. Genetic variation and microevolution of dengue 2 virus in Southeast Asia. , 1989, Virology.
[114] G. Kourí,et al. ANTIBODY-DEPENDENT ENHANCEMENT OF DENGUE 2 VIRUS IN PEOPLE OF WHITE DESCENT IN CUBA , 1987, The Lancet.
[115] S. Halstead. Dengue and hemorrhagic fevers of Southeast Asia. , 1965, The Yale journal of biology and medicine.
[116] T. Monath,et al. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. , 1997, Vaccine.
[117] G. Kuno,et al. Dengue 3 virus transmission in Africa. , 1986, The American journal of tropical medicine and hygiene.
[118] S. Lam,et al. Isolation of dengue viruses by intracerebral inoculation of mosquito larvae. , 1986, Journal of virological methods.
[119] L. Rosen,et al. A simple technique for the detection of dengue antigen in mosquitoes by immunofluorescence. , 1977, The American journal of tropical medicine and hygiene.
[120] G. Kuno,et al. Use of 'original antigenic sin' theory to determine the serotypes of previous dengue infections. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[121] C. Lai,et al. Genetic determinants of dengue type 4 virus neurovirulence for mice , 1993, Journal of virology.
[122] A. Igarashi,et al. Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. , 1978, The Journal of general virology.
[123] O. H. Pepper. A Note on David Bylon and Dengue , 1941, Annals of medical history.
[124] D. Gubler,et al. Dengue and dengue hemorrhagic fever in the Americas. , 1987, Puerto Rico health sciences journal.
[125] C. G. Moore,et al. Aedes albopictus in the United States: ten-year presence and public health implications. , 1997, Emerging infectious diseases.
[126] Dietz,et al. The 1986 dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations. , 1996, Puerto Rico health sciences journal.
[127] W. Hammon,et al. New hemorrhagic fevers of children in the Philippines and Thailand. , 1960, Transactions of the Association of American Physicians.
[128] S. Yoksan,et al. STUDY OF BIVALENT DENGUE VACCINE IN VOLUNTEERS , 1989, The Lancet.
[129] D. Chadee,et al. Community participation in dengue prevention and control: a survey of knowledge, attitudes, and practice in Trinidad and Tobago. , 1995, The American journal of tropical medicine and hygiene.
[130] Dengue type 3 infection--Nicaragua and Panama, October-November 1994. , 1995, MMWR. Morbidity and mortality weekly report.
[131] N. Bhamarapravati,et al. Live attenuated tetravalent dengue vaccine. , 2000, Vaccine.
[132] J. Rigau-Pérez. Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Puerto Rico Association of Epidemiologists. , 1997, Revista panamericana de salud publica = Pan American journal of public health.
[133] A. Nisalak,et al. Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus , 1997, Clinical and diagnostic laboratory immunology.
[134] D. Gubler,et al. Virological surveillance for dengue haemorrhagic fever in Indonesia using the mosquito inoculation technique. , 1979, Bulletin of the World Health Organization.
[135] M. Bray,et al. Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[136] D. Gubler,et al. Dengue and dengue hemorrhagic fever. , 2014 .
[137] D. Gubler,et al. Dengue and dengue hemorrhagic fever : Its history and resurgence as a global public health problem , 1997 .
[138] G. Kuno,et al. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990-1991. , 1995, American journal of epidemiology.
[139] Gubler Dj. The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. , 1998 .
[140] N. Bhamarapravati,et al. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. , 1967, Annals of tropical medicine and parasitology.
[141] D. E. Carey. Chikungunya and dengue: a case of mistaken identity? , 1971, Journal of the history of medicine and allied sciences.
[142] S. Halstead,et al. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.
[143] A. Nisalak,et al. Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: a randomized, controlled trial. , 1997, The Journal of pediatrics.
[144] J. F. Siler,et al. Dengue : Its History, Epidemiology, Mechanism of Transmission, Etiology, Clinical Manifestations, Immunity and Prevention. , 1926 .
[145] T. Scott,et al. Blood-feeding behavior of dengue-2 virus-infected Aedes aegypti. , 1995, The American journal of tropical medicine and hygiene.
[146] SB Halstead,et al. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody , 1977, The Journal of experimental medicine.
[147] D. Gubler. Arboviruses as imported disease agents: the need for increased awareness. , 1996, Archives of virology. Supplementum.
[148] S. Cohen,et al. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. , 1969 .
[149] D. Morens,et al. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[150] S. Rojanasuphot,et al. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. , 1993, Pediatrics.
[151] S. Halstead. Dengue and dengue hemorrhagic fever , 1990 .
[152] H. Bielefeldt-Ohmann. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. , 1997, Trends in microbiology.
[153] D. Gubler,et al. Community involvement in the control of Aedes aegypti. , 1996, Acta tropica.
[154] Robert H Levis,et al. Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast , 1997, Journal of virology.
[155] S. Halstead,et al. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. , 1984, Journal of immunology.
[156] G. Kuno,et al. Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses. , 1985, Bulletin of the World Health Organization.
[157] A. Nisalak,et al. A plaque reduction test for dengue virus neutralizing antibodies. , 1967, Journal of immunology.
[158] E. Paoletti,et al. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. , 1991, Virology.
[159] L. Whiteford. The ethnoecology of dengue fever. , 1997, Medical anthropology quarterly.
[160] D. Burke,et al. Antibody Capture Immunoassay Detection of Japanese Encephalitis Virus Immunoglobulin M and G Antibodies in Cerebrospinal Fluid , 1982, Journal of clinical microbiology.
[161] L. Rosen,et al. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. , 1977, The American journal of tropical medicine and hygiene.
[162] Sir Rickard Christophers. Aëdes Aegypti The Yellow Fever Mosquito: Its Life History, Bionomics and Structure , 1960 .
[163] Y. Tan,et al. Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. , 1996, Virology.
[164] M. Wallace,et al. Dengue fever in U.S. troops during Operation Restore Hope, Somalia, 1992-1993. , 1995, The American journal of tropical medicine and hygiene.
[165] G. Kuno,et al. Review of the factors modulating dengue transmission. , 1995, Epidemiologic reviews.
[166] F. L. Soper,et al. The Organization of Permanent Nation-Wide Anti-Aëdes aegypti. Measures in Brazil. , 1943 .
[167] S. Halstead,et al. Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. , 1969, The American journal of tropical medicine and hygiene.
[168] A. Nisalak,et al. Dengue in the early febrile phase: viremia and antibody responses. , 1997, The Journal of infectious diseases.
[169] S. Halstead,et al. Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.
[170] D. Gubler,et al. Viraemia in patients with naturally acquired dengue infection. , 1981, Bulletin of the World Health Organization.